Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study.

Saved in:
Bibliographic Details
Title: Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study.
Authors: Braun, I.M., Meyer, F.L., Gagne, J.J., Nabati, L., Yuppa, D.P., Carmona, M.A., Burstein, H.J., Suzuki, J., Nayak, M.M., Martins, Y.
Source: Psycho-Oncology. Aug2017, Vol. 26 Issue 8, p1087-1092. 6p. 2 Charts.
Subjects: Oncology, Medical marijuana, Medicinal plants, Expert evidence, Opioids, Benzodiazepines
Abstract: Background Expansion of medical marijuana (MM) laws in the United States may offer oncology new therapeutic options. However, the scientific evidence for MM remains in infancy. This study qualitatively explored professional opinion around the role of MM in cancer care. Methods Semistructured interviews were administered to a sample of individuals with expertise at the interface of MM and oncology nationally. Key informant criteria included an oncologic clinical or research background and any of the following: publications, research, or lectures on cannabinoids or cancer symptoms; involvement in the development of MM dispensaries or legislation; and early adoption of state MM certification procedures. A gold standard, grounded, inductive approach was used to identify underlying themes. Results Participants (N = 15) were predominantly male, in their sixth decade, working in academic settings. Themes ranged from strong beliefs in marijuana's medical utility to reservations about this notion, with calls for expansion of the scientific evidence base and more stringent MM production standards. All participants cited nausea as an appropriate indication, and 13 of 15 pain. Over one-third believed MM to have a more attractive risk profile than opioids and benzodiazepines. Conclusions Expert opinion was divided between convictions in marijuana's medicinal potential and guardedness in this assertion, with no participant refuting MM's utility outright. Emergent themes included that MM ameliorates cancer-related pain and nausea and is safer than certain conventional medications. Participants called for enhanced purity and production standards, and further research on MM's utility. [ABSTRACT FROM AUTHOR]
Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 124505862
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Braun%2C+I%2EM%2E%22">Braun, I.M.</searchLink><br /><searchLink fieldCode="AR" term="%22Meyer%2C+F%2EL%2E%22">Meyer, F.L.</searchLink><br /><searchLink fieldCode="AR" term="%22Gagne%2C+J%2EJ%2E%22">Gagne, J.J.</searchLink><br /><searchLink fieldCode="AR" term="%22Nabati%2C+L%2E%22">Nabati, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Yuppa%2C+D%2EP%2E%22">Yuppa, D.P.</searchLink><br /><searchLink fieldCode="AR" term="%22Carmona%2C+M%2EA%2E%22">Carmona, M.A.</searchLink><br /><searchLink fieldCode="AR" term="%22Burstein%2C+H%2EJ%2E%22">Burstein, H.J.</searchLink><br /><searchLink fieldCode="AR" term="%22Suzuki%2C+J%2E%22">Suzuki, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Nayak%2C+M%2EM%2E%22">Nayak, M.M.</searchLink><br /><searchLink fieldCode="AR" term="%22Martins%2C+Y%2E%22">Martins, Y.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Psycho-Oncology%22">Psycho-Oncology</searchLink>. Aug2017, Vol. 26 Issue 8, p1087-1092. 6p. 2 Charts.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Oncology%22">Oncology</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+marijuana%22">Medical marijuana</searchLink><br /><searchLink fieldCode="DE" term="%22Medicinal+plants%22">Medicinal plants</searchLink><br /><searchLink fieldCode="DE" term="%22Expert+evidence%22">Expert evidence</searchLink><br /><searchLink fieldCode="DE" term="%22Opioids%22">Opioids</searchLink><br /><searchLink fieldCode="DE" term="%22Benzodiazepines%22">Benzodiazepines</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background Expansion of medical marijuana (MM) laws in the United States may offer oncology new therapeutic options. However, the scientific evidence for MM remains in infancy. This study qualitatively explored professional opinion around the role of MM in cancer care. Methods Semistructured interviews were administered to a sample of individuals with expertise at the interface of MM and oncology nationally. Key informant criteria included an oncologic clinical or research background and any of the following: publications, research, or lectures on cannabinoids or cancer symptoms; involvement in the development of MM dispensaries or legislation; and early adoption of state MM certification procedures. A gold standard, grounded, inductive approach was used to identify underlying themes. Results Participants (N = 15) were predominantly male, in their sixth decade, working in academic settings. Themes ranged from strong beliefs in marijuana's medical utility to reservations about this notion, with calls for expansion of the scientific evidence base and more stringent MM production standards. All participants cited nausea as an appropriate indication, and 13 of 15 pain. Over one-third believed MM to have a more attractive risk profile than opioids and benzodiazepines. Conclusions Expert opinion was divided between convictions in marijuana's medicinal potential and guardedness in this assertion, with no participant refuting MM's utility outright. Emergent themes included that MM ameliorates cancer-related pain and nausea and is safer than certain conventional medications. Participants called for enhanced purity and production standards, and further research on MM's utility. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=124505862
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pon.4365
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 1087
    Subjects:
      – SubjectFull: Oncology
        Type: general
      – SubjectFull: Medical marijuana
        Type: general
      – SubjectFull: Medicinal plants
        Type: general
      – SubjectFull: Expert evidence
        Type: general
      – SubjectFull: Opioids
        Type: general
      – SubjectFull: Benzodiazepines
        Type: general
    Titles:
      – TitleFull: Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Braun, I.M.
      – PersonEntity:
          Name:
            NameFull: Meyer, F.L.
      – PersonEntity:
          Name:
            NameFull: Gagne, J.J.
      – PersonEntity:
          Name:
            NameFull: Nabati, L.
      – PersonEntity:
          Name:
            NameFull: Yuppa, D.P.
      – PersonEntity:
          Name:
            NameFull: Carmona, M.A.
      – PersonEntity:
          Name:
            NameFull: Burstein, H.J.
      – PersonEntity:
          Name:
            NameFull: Suzuki, J.
      – PersonEntity:
          Name:
            NameFull: Nayak, M.M.
      – PersonEntity:
          Name:
            NameFull: Martins, Y.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2017
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-print
              Value: 10579249
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Psycho-Oncology
              Type: main
ResultId 1